That Marketing Solution, Inc. (TSTS) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerThat Marketing Solution, Inc. (TSTS) trades at $0.00001. That Marketing Solution, Inc. is a development stage company focused on nutritional products, specifically Low-T capsules, an over-the-counter supplement targeting decreased testosterone levels in men. Sector: Consumer staples.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for TSTS: TSTS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
That Marketing Solution, Inc. (TSTS) Consumer Business Overview
That Marketing Solution, Inc. is a development-stage company in the healthcare sector, focusing on the development, manufacturing, and marketing of nutritional supplements, primarily Low-T capsules. These capsules target decreased testosterone levels in men over 30, offering a natural, over-the-counter solution in a competitive market.
What Is the Investment Thesis for TSTS?
That Marketing Solution, Inc. presents a high-risk, high-reward investment opportunity given its development stage and focus on a single product. The potential success of Low-T capsules hinges on effective marketing and consumer adoption in a competitive market. Key value drivers include successful product launch, positive consumer reviews, and expansion of distribution channels. The company's financial performance is currently characterized by negative profit and gross margins (-159019.4% and -4125.5%, respectively), reflecting its development stage. A successful market entry could lead to significant revenue growth, but the company's small size and limited resources pose substantial risks. Investors should closely monitor the company's progress in securing funding, establishing manufacturing capabilities, and executing its marketing strategy. The high beta of 8.85 indicates significant volatility.
Based on FMP financials and quantitative analysis
TSTS Key Highlights
Market capitalization of $0.00B, reflecting its development stage and limited operations.
- Negative P/E ratio of -0.00, indicative of current losses and lack of profitability.
- Profit margin of -159019.4%, highlighting the significant expenses relative to revenue.
- Gross margin of -4125.5%, showing the high cost of goods sold compared to revenue.
- Beta of 8.85, indicating high volatility compared to the market.
Who Are TSTS's Competitors?
TSTS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| LGND Ligand Pharmaceuticals Incorporated | $302.96 | +0.07% | $6.07B | 96 5-pillar |
| TANH Tantech Holdings Ltd | $14.79 | +6.56% | $9.87M | — |
| MTEX Mannatech, Incorporated | $6.64 | -4.94% | $12.8M | — |
| DSY Big Tree Cloud Holdings Limited | $3.56 | +2.30% | $16.9M | — |
| UG United-Guardian, Inc. | $7.13 | +0.42% | $32.8M | — |
| AXIL AXIL Brands, Inc. | $6.17 | -0.32% | $42.1M | — |
| GROV Grove Collaborative Holdings, Inc. | $1.04 | +1.96% | $43.7M | — |
| SLSN Solésence, Inc. | $0.82 | -1.71% | $57.9M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TSTS's Key Strengths?
Proprietary formula for Low-T capsules.
- Focus on a specific niche market.
- Potential for direct-to-consumer sales.
What Are TSTS's Weaknesses?
Development stage company with limited resources.
- Reliance on a single product.
- Negative profit and gross margins.
What Are the Key Risks for TSTS?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from established companies in the nutritional supplement market.
- Regulatory scrutiny and potential changes in regulations governing nutritional supplements.
- Limited financial resources and potential need for additional funding.
- Dependence on a single product (Low-T capsules).
- Low liquidity of the stock due to trading on the OTC market.
What Are TSTS's Competitive Advantages?
- Proprietary formula for Low-T capsules.
- Focus on a specific niche market (testosterone-boosting supplements).
- Potential for brand recognition and customer loyalty in the niche market.
What Does TSTS Do?
That Marketing Solution, Inc., founded in 2012 and based in Salt Lake City, Utah, operates as a development stage company within the healthcare sector. The company focuses on the development, manufacturing, advertising, sale, and marketing of nutritional products. Its primary product is Low-T capsules, a proprietary formula blend of nutritional supplements designed to address decreased testosterone levels in males over the age of 30. These capsules are intended to be a natural, non-FDA regulated, and over-the-counter supplement. The company's history includes a name change from Vista Holding Group, Corp. to That Marketing Solution, Inc. in September 2014. Currently, the company is in the development phase, focusing on establishing its presence in the nutritional supplement market. With a small team of two employees, the company is working to bring its Low-T capsules to market. The company's strategy revolves around marketing a non-regulated supplement directly to consumers seeking natural solutions for age-related testosterone decline. The company faces competition from established pharmaceutical and nutraceutical companies, requiring a focused and effective marketing approach to gain market share.
What Products and Services Does TSTS Offer?
- Develop nutritional products
- Manufacture nutritional supplements
- Advertise nutritional products
- Sell nutritional products
- Market nutritional products
- Focus on Low-T capsules, a blend of nutritional supplements
How Does TSTS Make Money?
- Develop and acquire proprietary formulas for nutritional supplements.
- Manufacture supplements or outsource manufacturing.
- Market and sell supplements directly to consumers or through distributors.
What Industry Does TSTS Operate In?
That Marketing Solution, Inc. operates within the competitive nutritional supplement industry, specifically targeting the market for testosterone-boosting products. This market is driven by an aging male population seeking to mitigate the effects of declining testosterone levels. The industry includes both pharmaceutical companies offering prescription testosterone replacement therapies and nutraceutical companies providing over-the-counter supplements. The market is characterized by intense competition, evolving consumer preferences, and regulatory scrutiny. Companies like ACUS, EMYSF, IRBS, LGND, and NEPTF also operate in the broader healthcare and pharmaceutical space, offering a range of products and services. Success in this market requires effective marketing, product differentiation, and adherence to quality standards.
Who Are TSTS's Key Customers?
- Males over the age of 30 experiencing decreased testosterone levels.
- Individuals seeking natural, over-the-counter solutions for health concerns.
- Consumers interested in nutritional supplements and wellness products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
That Marketing Solution, Inc. operates in the Consumer Defensive sector. It is headquartered in Salt Lake City, US. The company is led by CEO Darren J. Lopez. TSTS has traded publicly since 2014.
Key Financial Metrics
Return on equity for That Marketing Solution, Inc. stands at 231.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.15 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
That Marketing Solution, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
TSTS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
TSTS Latest News
No recent news available for TSTS.
TSTS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TSTS.
Price Targets
Wall Street price target analysis for TSTS.
TSTS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for TSTS; grades run from A+ (80-100) to F (below 30).
Leadership: Darren J. Lopez
CEO
Darren J. Lopez is the CEO of That Marketing Solution, Inc. His background includes experience in managing small teams and overseeing the development and marketing of nutritional products. He has been instrumental in guiding the company through its development stage, focusing on securing the rights to the Low-T capsule formula and establishing the company's initial marketing strategy. His leadership is focused on building a brand presence and driving sales in the competitive nutritional supplement market.
Track Record: Under Darren J. Lopez's leadership, That Marketing Solution, Inc. has acquired the rights to the Low-T capsule formula and initiated its development and marketing efforts. He has focused on building a direct-to-consumer sales model and establishing partnerships with key distributors. The company is currently in the early stages of commercializing its product, and its success will depend on his ability to execute the company's growth strategy.
TSTS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that That Marketing Solution, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Low liquidity and high bid-ask spreads.
- Potential for price manipulation and volatility.
- Higher risk of fraud or mismanagement compared to exchange-listed companies.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any regulatory actions or legal disputes.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company registration and good standing with regulatory authorities.
- Availability of some financial information, even if limited.
- A clear business plan and market strategy.
- Active communication with investors and stakeholders.
- Positive customer reviews or testimonials (if available).
TSTS Consumer Staples Stock FAQ
What do analysts say about TSTS stock?
As of March 17, 2026, there is no available analyst coverage for That Marketing Solution, Inc. due to its development stage and OTC listing. Key valuation metrics such as P/E ratio (-0.00) and profit margin (-159019.4%) reflect the company's current losses and lack of profitability.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available due to the company's development stage and OTC listing.
- Financial data is based on available information and may not be comprehensive.